News, reviews and podcasts from annual scientific meetings and symposiums around the world.
The Oncology Podcast, brought to you by www.oncologynews.com.au, is proud to present the next episode…
Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of…
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping…
The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol…
By analysing tumours from patients treated with immunotherapy for advanced kidney cancer in three clinical…
The targeted therapy pralsetinib appears to have high response rates and durable activity in patients…
Researchers at Fox Chase Cancer Center, USA, along with an international team of investigators, have…
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was…
Front-line therapy with the immune checkpoint inhibitor pembrolizumab doubled progression-free survival vs chemotherapy in patients…
Among patients with lung and other thoracic cancers also diagnosed with COVID-19, prior use of…